.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Moodys
Deloitte
QuintilesIMS
Daiichi Sankyo
Medtronic
Citi
Johnson and Johnson
Chinese Patent Office

Generated: June 29, 2017

DrugPatentWatch Database Preview

IBUTILIDE FUMARATE Drug Profile

« Back to Dashboard

What is the patent landscape for Ibutilide Fumarate, and when can generic versions of Ibutilide Fumarate launch?

Ibutilide Fumarate is a drug marketed by Mylan Institutional and Luitpold and is included in three NDAs.

The generic ingredient in IBUTILIDE FUMARATE is ibutilide fumarate. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ibutilide fumarate profile page.

Summary for Tradename: IBUTILIDE FUMARATE

Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list2
Bulk Api Vendors: see list25
Clinical Trials: see list539
Patent Applications: see list235
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IBUTILIDE FUMARATE at DailyMed

Pharmacology for Tradename: IBUTILIDE FUMARATE

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
IBUTILIDE FUMARATE
ibutilide fumarate
INJECTABLE;INJECTION090924-001Jan 11, 2010APRXNoNo► Subscribe► Subscribe
Luitpold
IBUTILIDE FUMARATE
ibutilide fumarate
INJECTABLE;INJECTION090240-001Jan 11, 2010APRXNoNo► Subscribe► Subscribe
Mylan Institutional
IBUTILIDE FUMARATE
ibutilide fumarate
INJECTABLE;INJECTION090643-001Jan 11, 2010APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
US Department of Justice
Baxter
Colorcon
Novartis
Cipla
Accenture
Healthtrust
Harvard Business School
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot